Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

See our updated masking policy »

Stanford Health Care

Ovarian Carcinosarcomas Associated With Prolonged Use of Tamoxifen Case Reports INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER Lavie, O., Longacre, T., Segev, Y., Husain, A. 2009; 19 (9): 1521-1523

Abstract

Recent studies have indicated that the risk associated with tamoxifen may be substantially higher for uterine malignant mixed müllerian tumors and uterine sarcomas.We present 2 cases of ovarian carcinosarcomas in patients with a personal history of breast carcinoma who were treated for a prolonged period with tamoxifen.To our knowledge, these 2 cases are the first to describe the possible association between ovarian carcinosarcomas and previous personal and familial history of breast carcinoma and\or prolonged use of tamoxifen. These cases may suggest that like in the uterus, tamoxifen has a possible delayed effect, which might be responsible for the formation of aggressive tumors of unclear pathogenesis in the ovaries.

View details for DOI 10.1111/IGC.0b013e3181a83fbf

View details for Web of Science ID 000272898400010

View details for PubMedID 19955929